The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Circulating levels of RANK/RANKL and OPG in patients with bone metastasis treated with zoledronic acid: A prospective study.
T. Ibrahim
No relevant relationships to disclose
L. Mercatali
No relevant relationships to disclose
E. Sacanna
No relevant relationships to disclose
R. Ricci
No relevant relationships to disclose
E. Scarpi
No relevant relationships to disclose
P. Serra
No relevant relationships to disclose
F. Fabbri
No relevant relationships to disclose
C. Tison
No relevant relationships to disclose
D. Amadori
No relevant relationships to disclose